A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country.
Some public health experts hope that Americans will welcome the new shot as they would a flu jab. But demand for the vaccine has dropped sharply since 2021 when it first became available and more than 240 million people in the U.S., or 73% of the population, received at least one shot.
Healthcare providers and pharmacies such as CVS Health will start next month to offer the shot, updated to fight the Omicron version of the virus that has been dominant since last year.
Read the full article.
— Reuters (@Reuters) August 14, 2023